Peritoneal cancer, also called primary peritoneal cancer, is a rare type of cancer, occurring in fewer than seven out of every million people in the United States. The peritoneum is a membrane ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

The authorisation allows the therapy to be used as a single agent for the maintenance treatment of adult individuals with advanced high-grade ovarian, fallopian tube or primary peritoneal cancer who ...

Real-world safety of trastuzumab deruxtecan with gastric cancer: All-patient post-marketing surveillance study in Japan. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...

The move is part of a strategic restructuring aimed at getting azenosertib to the market for patients with gynecological ...

Neoadjuvant PD-1 blockade in mismatch repair-deficient or microsatellite instability-high, locally advanced and resectable colorectal cancer: A retrospective real-world analysis. This is an ASCO ...

Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 improved survival in patients with gastric cancer and peritoneal metastasis.

Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.

PNN New Delhi [India], January 25: A three-day conference on Peritoneal Surface malignancy was held at Thangam Hospital and Cancer Center, Namakkal. Peritoneal Surface malignancy (PSM) is a super ...